Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Assets (2018 - 2021)

Cogent Biosciences has reported Return on Assets over the past 4 years, most recently at 0.27% for Q3 2021.

  • Quarterly results put Return on Assets at 0.27% for Q3 2021, up 53.0% from a year ago — trailing twelve months through Sep 2021 was 0.27% (up 53.0% YoY), and the annual figure for FY2020 was 0.55%, down 7.0%.
  • Return on Assets for Q3 2021 was 0.27% at Cogent Biosciences, up from 0.42% in the prior quarter.
  • Over the last five years, Return on Assets for COGT hit a ceiling of 0.27% in Q3 2021 and a floor of 0.8% in Q3 2020.
  • Median Return on Assets over the past 4 years was 0.47% (2019), compared with a mean of 0.5%.
  • Biggest five-year swings in Return on Assets: plummeted -34bps in 2019 and later soared 53bps in 2021.
  • Cogent Biosciences' Return on Assets stood at 0.39% in 2018, then tumbled by -54bps to 0.59% in 2019, then rose by 29bps to 0.42% in 2020, then surged by 35bps to 0.27% in 2021.
  • The last three reported values for Return on Assets were 0.27% (Q3 2021), 0.42% (Q2 2021), and 0.36% (Q1 2021) per Business Quant data.